Amgen Technology Ireland Unlimited vs. Alexion Pharmaceuticals - APP_43687/2024

The UPC Case APP_43687/2024 was filed on 29 Jul, 2024 by the plaintiff Amgen Technology Ireland Unlimited against the defendant Alexion Pharmaceuticals.

Case Details

    Case Number:

    APP_43687/2024

    Patent Number:

    Filing Date:

    29 Jul, 2024

    Proceeding Type:

    Generic

    Case Phase:

    Written Phase

    Plaintiffs:

    • Amgen Technology Ireland Unlimited

    Plaintiff Representatives:

    • Tilman MUELLER-STOY

    Defendants:

    • Alexion Pharmaceuticals

    Defendant Representatives:

    • Elena HENNECKE

    Judges:

    • Alima Zana
    • Rudi Goedeweeck
    • Sabine Klepsch
    • Stefan Schilling

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

DateTitleLink
Sep 11, 2025Receipt-
Sep 11, 2025Brief Re Cost Application First Instance Amgen-
Aug 20, 2025Receipt-
Aug 19, 2025Rule 262.2 Application-
Aug 19, 2025Comments-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds
Aug 5, 2025Anhoerung-
Aug 4, 2025Comments-
Jul 29, 2025Anhoerung-
Jul 15, 2025Receipt-
Jul 14, 2025Costs Awarded Reply Confidential En Signed-
Jul 14, 2025Confidentiality Requests En Signed-
Jul 2, 2025Anhoerung-
Sep 9, 2024Submission-
Sep 9, 2024Comments-
Aug 12, 2024Anhoerung Kosten-
Jul 29, 2024Receipt-
Jul 26, 2024Application-
Sep 11, 2025Receipt-
Sep 11, 2025Brief Re Cost Application First Instance Amgen-
Aug 20, 2025Receipt-
Aug 19, 2025Rule 262.2 Application-
Aug 19, 2025Comments-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds
Aug 5, 2025Anhoerung-
Aug 4, 2025Comments-
Jul 29, 2025Anhoerung-
Jul 15, 2025Receipt-
Jul 14, 2025Costs Awarded Reply Confidential En Signed-
Jul 14, 2025Confidentiality Requests En Signed-
Jul 2, 2025Anhoerung-
Sep 9, 2024Submission-
Sep 9, 2024Comments-
Aug 12, 2024Anhoerung Kosten-
Jul 29, 2024Receipt-
Jul 26, 2024Application-
Sep 11, 2025Receipt-
Sep 11, 2025Brief Re Cost Application First Instance Amgen-
Aug 20, 2025Receipt-
Aug 19, 2025Rule 262.2 Application-
Aug 19, 2025Comments-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds
Aug 5, 2025Anhoerung-
Aug 4, 2025Comments-
Jul 29, 2025Anhoerung-
Jul 15, 2025Receipt-
Jul 14, 2025Costs Awarded Reply Confidential En Signed-
Jul 14, 2025Confidentiality Requests En Signed-
Jul 2, 2025Anhoerung-
Sep 9, 2024Submission-
Sep 9, 2024Comments-
Aug 12, 2024Anhoerung Kosten-
Jul 29, 2024Receipt-
Jul 26, 2024Application-
Sep 11, 2025Receipt-
Sep 11, 2025Brief Re Cost Application First Instance Amgen-
Aug 20, 2025Receipt-
Aug 19, 2025Rule 262.2 Application-
Aug 19, 2025Comments-
Aug 5, 2025Outcome Of The Order-
Aug 5, 2025Order With Grounds
Aug 5, 2025Anhoerung-
Aug 4, 2025Comments-
Jul 29, 2025Anhoerung-
Jul 15, 2025Receipt-
Jul 14, 2025Costs Awarded Reply Confidential En Signed-
Jul 14, 2025Confidentiality Requests En Signed-
Jul 2, 2025Anhoerung-
Sep 9, 2024Submission-
Sep 9, 2024Comments-
Aug 12, 2024Anhoerung Kosten-
Jul 29, 2024Receipt-
Jul 26, 2024Application-

More cases involving EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_674/2025Jul 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_51/2025Jan 23, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_40/2025Jan 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals

More cases involving Amgen Technology Ireland Unlimited

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35200/2025Aug 21, 2025Amgen Technology Ireland Unlimited -
App_35086/2025Aug 20, 2025Amgen Technology Ireland Unlimited -
App_35087/2025Aug 20, 2025Amgen Technology Ireland Unlimited -

More cases involving Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 9, 2025
Case NumberFiling DatePlaintiffsDefendants
App_35353/2025Aug 22, 2025Alexion Pharmaceuticals -
ORD_35357/2025Aug 22, 2025Samsung BioepisAlexion Pharmaceuticals
App_35118/2025Aug 20, 2025Alexion Pharmaceuticals -